Author details

Full Name

Yuelin J Zhu

Affiliation

National Cancer Institute, National Institutes of Health

ORCID

Career Start Year

2002

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36103385	Morphological and Functional Colonic Defects Caused by a Mutated Thyroid Hormone Receptor Î±.	Thyroid	2023
36103385	Morphological and Functional Colonic Defects Caused by a Mutated Thyroid Hormone Receptor Î±.	Thyroid	2023
37634007	Thyroid hormone receptor Î±1: a novel regulator of thyroid cancer cell differentiation.	Oncogene	2023
37147424	NUP98::Nsd1 and FLT3-ITD collaborate to generate acute myeloid leukemia.	Leukemia	2023
37453305	Bacterial wilt suppressive composts: Significance of rhizosphere microbiome.	Waste Manag	2023
37634007	Thyroid hormone receptor Î±1: a novel regulator of thyroid cancer cell differentiation.	Oncogene	2023
37453305	Bacterial wilt suppressive composts: Significance of rhizosphere microbiome.	Waste Manag	2023
37147424	NUP98::Nsd1 and FLT3-ITD collaborate to generate acute myeloid leukemia.	Leukemia	2023
35256781	Regulation of cancer stem cell activity by thyroid hormone receptor Î².	Oncogene	2022
35920299	Mcm2 hypomorph leads to acute leukemia or hematopoietic stem cell failure, dependent on genetic context.	FASEB J	2022
35256781	Regulation of cancer stem cell activity by thyroid hormone receptor Î².	Oncogene	2022
35920299	Mcm2 hypomorph leads to acute leukemia or hematopoietic stem cell failure, dependent on genetic context.	FASEB J	2022
34321240	Mutant <i>Idh2</i> Cooperates with a <i>NUP98-HOXD13</i> Fusion to Induce Early Immature Thymocyte Precursor ALL.	Cancer Res	2021
34321240	Mutant <i>Idh2</i> Cooperates with a <i>NUP98-HOXD13</i> Fusion to Induce Early Immature Thymocyte Precursor ALL.	Cancer Res	2021
34818552	Immuno-transcriptomic profiling of extracranial pediatric solid malignancies.	Cell Rep	2021
34818552	Immuno-transcriptomic profiling of extracranial pediatric solid malignancies.	Cell Rep	2021
32706863	Distinct DNA Methylation Signatures in Neuroendocrine Tumors Specific for Primary Site and Inherited Predisposition.	J Clin Endocrinol Metab	2020
32014861	Corrigendum: 1q21.1 deletion and a rare functional polymorphism in siblings with thrombocytopenia-absent radius-like phenotypes.	Cold Spring Harb Mol Case Stud	2020
31952464	Generation of Novel Genetic Models to Dissect Resistance to Thyroid Hormone Receptor Î± in Zebrafish.	Thyroid	2020
32001692	Author Correction: Recurrent PTPRT/JAK2 mutations in lung adenocarcinoma among African Americans.	Nat Commun	2020
32041821	A Circular RNA from the <i>MDM2</i> Locus Controls Cell Cycle Progression by Suppressing p53 Levels.	Mol Cell Biol	2020
32706863	Distinct DNA Methylation Signatures in Neuroendocrine Tumors Specific for Primary Site and Inherited Predisposition.	J Clin Endocrinol Metab	2020
33108271	The S-phase-induced lncRNA <i>SUNO1</i> promotes cell proliferation by controlling YAP1/Hippo signaling pathway.	Elife	2020
32001692	Author Correction: Recurrent PTPRT/JAK2 mutations in lung adenocarcinoma among African Americans.	Nat Commun	2020
31952464	Generation of Novel Genetic Models to Dissect Resistance to Thyroid Hormone Receptor Î± in Zebrafish.	Thyroid	2020
32014861	Corrigendum: 1q21.1 deletion and a rare functional polymorphism in siblings with thrombocytopenia-absent radius-like phenotypes.	Cold Spring Harb Mol Case Stud	2020
32041821	A Circular RNA from the <i>MDM2</i> Locus Controls Cell Cycle Progression by Suppressing p53 Levels.	Mol Cell Biol	2020
33108271	The S-phase-induced lncRNA <i>SUNO1</i> promotes cell proliferation by controlling YAP1/Hippo signaling pathway.	Elife	2020
30872698	Rapid and reversible suppression of ALT by DAXX in osteosarcoma cells.	Sci Rep	2019
31748606	Thymic precursor cells generate acute myeloid leukemia in NUP98-PHF23/NUP98-HOXD13 double transgenic mice.	Sci Rep	2019
31836590	1q21.1 deletion and a rare functional polymorphism in siblings with thrombocytopenia-absent radius-like phenotypes.	Cold Spring Harb Mol Case Stud	2019
31622281	A unique mutator phenotype reveals complementary oncogenic lesions leading to acute leukemia.	JCI Insight	2019
30872698	Rapid and reversible suppression of ALT by DAXX in osteosarcoma cells.	Sci Rep	2019
30865533	ONCOGENE PANEL SEQUENCING ANALYSIS IDENTIFIES CANDIDATE ACTIONABLE GENES IN ADVANCED WELL-DIFFERENTIATED GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS.	Endocr Pract	2019
30992267	Engineered Bcor mutations lead to acute leukemia of progenitor B-1 lymphocyte origin in a sensitized background.	Blood	2019
31836590	1q21.1 deletion and a rare functional polymorphism in siblings with thrombocytopenia-absent radius-like phenotypes.	Cold Spring Harb Mol Case Stud	2019
31748606	Thymic precursor cells generate acute myeloid leukemia in NUP98-PHF23/NUP98-HOXD13 double transgenic mice.	Sci Rep	2019
31622281	A unique mutator phenotype reveals complementary oncogenic lesions leading to acute leukemia.	JCI Insight	2019
30865533	ONCOGENE PANEL SEQUENCING ANALYSIS IDENTIFIES CANDIDATE ACTIONABLE GENES IN ADVANCED WELL-DIFFERENTIATED GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS.	Endocr Pract	2019
30992267	Engineered Bcor mutations lead to acute leukemia of progenitor B-1 lymphocyte origin in a sensitized background.	Blood	2019
29187393	Outcomes of Children and Adolescents with Advanced Hereditary Medullary Thyroid Carcinoma Treated with Vandetanib.	Clin Cancer Res	2018
29967250	Dynamics of Genome Alterations in Crohn's Disease-Associated Colorectal Carcinogenesis.	Clin Cancer Res	2018
30102375	MIR100 host gene-encoded lncRNAs regulate cell cycle by modulating the interaction between HuR and its target mRNAs.	Nucleic Acids Res	2018
29187393	Outcomes of Children and Adolescents with Advanced Hereditary Medullary Thyroid Carcinoma Treated with Vandetanib.	Clin Cancer Res	2018
29181861	Aneuploidy, TP53 mutation, and amplification of MYC correlate with increased intratumor heterogeneity and poor prognosis of breast cancer patients.	Genes Chromosomes Cancer	2018
30102375	MIR100 host gene-encoded lncRNAs regulate cell cycle by modulating the interaction between HuR and its target mRNAs.	Nucleic Acids Res	2018
29967250	Dynamics of Genome Alterations in Crohn's Disease-Associated Colorectal Carcinogenesis.	Clin Cancer Res	2018
29181861	Aneuploidy, TP53 mutation, and amplification of MYC correlate with increased intratumor heterogeneity and poor prognosis of breast cancer patients.	Genes Chromosomes Cancer	2018
27440272	Bromodomain and Extraterminal Protein Inhibitor JQ1 Suppresses Thyroid Tumor Growth in a Mouse Model.	Clin Cancer Res	2017
28648284	Common Molecular Subtypes Among Asian Hepatocellular Carcinoma and Cholangiocarcinoma.	Cancer Cell	2017

1 - 50 of 134

Ganiraju C Manyam

the University of Texas MD Anderson Cancer Center

Career Start Year 2009

Number of shared co-authors 0

Ritu Roy

University of California San Francisco.

Career Start Year 2007

Number of shared co-authors 2

Christopher A Bristow

The University of Texas MD Anderson Cancer Center

Career Start Year 2005

Number of shared co-authors 0

Steffen Durinck

Genentech Inc.

Career Start Year 2004

Number of shared co-authors 4

Andrew V Kossenkov

The Wistar Institute

Career Start Year 2003

Number of shared co-authors 3

Jianmin Wang

Roswell Park Comprehensive Cancer Center

Career Start Year 2003

Number of shared co-authors 0

Joel S Parker

Lineberger Cancer Center, University of North Carolina

Career Start Year 2002

Number of shared co-authors 5

Michael Slifker

Fox Chase Cancer Center

Career Start Year 2002

Number of shared co-authors 0

Yidong Chen

The University of Texas Health Science Center at San Antonio

Career Start Year 2001

Number of shared co-authors 7

Andrew J Gentles

Stanford Center for Biomedical Informatics Research, Stanford University

Career Start Year 1999

Number of shared co-authors 0

Celine Lefebvre

The Scripps Research Institute

Career Start Year 1999

Number of shared co-authors 0

Jianjun Shen

The University of Texas MD Anderson Cancer Center

Career Start Year 1998

Number of shared co-authors 2

Paul T Spellman

Oregon Health & Science University Hospital.

Career Start Year 1998

Number of shared co-authors 4

Jun Yao

The University of Texas MD Anderson Cancer Center

Career Start Year 1997

Number of shared co-authors 0

Dongquan Chen

University of Alabama at Birmingham

Career Start Year 1997

Number of shared co-authors 1

Lianbo Yu

The Ohio State University

Career Start Year 1997

Number of shared co-authors 0

Benedikt Brors

German Cancer Research Center (DKFZ)

Career Start Year 1997

Number of shared co-authors 4

Agnes Viale

Memorial Sloan Kettering Cancer Center

Career Start Year 1996

Number of shared co-authors 3

Woong-Yang Park

Samsung Genome Institute, Samsung Medical Center

Career Start Year 1995

Number of shared co-authors 0

Adam B Olshen

12224University of California san francisco

Career Start Year 1993

Number of shared co-authors 1

Samuel Aparicio

University of British Columbia

Career Start Year 1993

Number of shared co-authors 0

Todd R Golub

Broad Institute of MIT and Harvard

Career Start Year 1989

Number of shared co-authors 5

Luigi Marchionni

Weill-Cornell School of Medicine

Career Start Year 1989

Number of shared co-authors 2

Wei Zhang

The University of Texas MD Anderson Cancer Center

Career Start Year 1988

Number of shared co-authors 1

Patrick Kwok-Shing Ng

The University of Texas MD Anderson Cancer Center

Career Start Year 1987

Number of shared co-authors 0

Mark A Watson

Washington University School of Medicine

Career Start Year 1987

Number of shared co-authors 2

Jonathan R Pollack

Stanford University School of Medicine

Career Start Year 1987

Number of shared co-authors 1

Andrew D Cherniack

Dana-Farber Cancer Institute

Career Start Year 1984

Number of shared co-authors 5

David D L Bowtell

Peter MacCallum Cancer Centre

Career Start Year 1983

Number of shared co-authors 2

Edison T Liu

USA The Jackson Laboratory Cancer Center

Career Start Year 1982

Number of shared co-authors 6

row(s) 1 - 30 of 30

Paul S Meltzer

Center for Cancer Research, National Cancer Institute, National Institutes of Health

Co-authored papers 46

Robert L Walker

Center for Cancer Research, National Cancer Institute, National Institutes of Health

Co-authored papers 25

Marbin Pineda

Center for Cancer Research, National Cancer Institute

Co-authored papers 13

Sven Bilke

Center for Cancer Research, National Cancer Institute, National Institutes of Health

Co-authored papers 10

Sheue-Yann Cheng

National Cancer Institute, National Institutes of Health

Co-authored papers 10

Jonathan K Killian

From Foundation Medicine

Co-authored papers 8

Joshua J Waterfall

INSERM U, PSL Research University, Institut Curie Research Center

Co-authored papers 6

Susan R Davis

Co-authored papers 5

Sean Davis

Johns Hopkins School of Medicine, National Cancer Institute, Princeton University, University of Colorado Anschutz Medical Campus, University of Pittsburgh, University of Washington

Co-authored papers 5

Yuan Jiang

Center for Cancer Research, National Cancer Institute, National Institutes of Health

Co-authored papers 4

Lee J Helman

Osteosarcoma Institute

Co-authored papers 4

Daniel C Edelman

Center for Cancer Research, National Cancer Institute, National Institutes of Health

Co-authored papers 4

Yonghong Wang

Center for Cancer Research, National Cancer Institute, National Institutes of Health